NCCN Guidelines® Insights: Colorectal Cancer Screening, Version 1.2024. Read more about NCCN Guidelines® Insights: Colorectal Cancer Screening, Version 1.2024.
NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024. Read more about NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024.
Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. Read more about Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Establishing Consensus for Mohs Micrographic Surgical Techniques in the Treatment of Melanoma in Situ for Future Clinical Trials: A Modified Delphi Study. Read more about Establishing Consensus for Mohs Micrographic Surgical Techniques in the Treatment of Melanoma in Situ for Future Clinical Trials: A Modified Delphi Study.
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024. Read more about NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024.
Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. Read more about Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. Read more about Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology Read more about Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology
NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024. Read more about NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024.
CRE24-034: Successful Management of Locally Advanced and Oligometastatic Urothelial Carcinoma With Pembrolizumab-Based Induction Regimen Followed by Consolidative Radical Resection of the Primary Tumor: A Multi-Institutional Case Series. Read more about CRE24-034: Successful Management of Locally Advanced and Oligometastatic Urothelial Carcinoma With Pembrolizumab-Based Induction Regimen Followed by Consolidative Radical Resection of the Primary Tumor: A Multi-Institutional Case Series.